IL-9 induces IL-8 production via STIM1 activation and ERK phosphorylation in epidermal keratinocytes: A plausible mechanism of IL-9R in atopic dermatitis

Journal of Dermatological Science

Volumn 78, Issue 3, 2015, Pages 206-214

  Hong, Chien Hui ^a,b,c   Chang, Kee Lung ^a   Wang, Hung Jen ^d   Yu, Hsin Su ^e,f   Lee, Chih Hung ^d,g  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^e KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^f NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^g CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

ERK; IL 8; IL 9; IL 9R; Keratinocytes; STIM1

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; CXCL16 CHEMOKINE; INTERLEUKIN 33; INTERLEUKIN 8; INTERLEUKIN 9; INTERLEUKIN 9 RECEPTOR; MACROPHAGE DERIVED CHEMOKINE; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; RAPAMYCIN; S6 KINASE; STAT3 PROTEIN; STROMAL INTERACTION MOLECULE 1; SYNAPTOPHYSIN; THYMIC STROMAL LYMPHOPOIETIN; TRANSFORMING GROWTH FACTOR BETA1; IL9R PROTEIN, HUMAN; INTERLEUKIN 4; MEMBRANE PROTEIN; STIM1 PROTEIN, HUMAN; TUMOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOPIC DERMATITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME PHOSPHORYLATION; EPIDERMIS CELL; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOGENESIS; IMMUNOREGULATION; IN VITRO STUDY; KERATINOCYTE; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; CYTOLOGY; DERMATITIS, ATOPIC; EPIDERMIS; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY;

ANIMALS; CELLS, CULTURED; DERMATITIS, ATOPIC; EPIDERMIS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; HUMANS; INTERLEUKIN-4; INTERLEUKIN-8; INTERLEUKIN-9; KERATINOCYTES; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; NEOPLASM PROTEINS; PHOSPHORYLATION; RECEPTORS, INTERLEUKIN-9;

EID: 84929050707     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2015.03.004     Document Type: Article

References (48)

1. Lee C.H., Chuang H.Y., Shih C.C., Jong S.B., Chang C.H., Yu H.S. Transepidermal water loss, serum IgE and beta-endorphin as important and independent biological markers for development of itch intensity in atopic dermatitis. Br J Dermatol 2006, 154:1100-1107.
2. Leung D.Y., Bieber T. Atopic dermatitis. Lancet 2003, 361:151-160.
3. Tokura Y. Extrinsic and intrinsic types of atopic dermatitis. J Dermatol Sci 2010, 58:1-7.
4. Irvine A.D., McLean W.H., Leung D.Y. Filaggrin mutations associated with skin and allergic diseases. N Engl J Med 2011, 365::1315-1327.
5. Siracusa M.C., Saenz S.A., Hill D.A., Kim B.S., Headley M.B., Doering T.A., et al. TSLP promotes interleukin-3-independent basophil haematopoiesis and type 2 inflammation. Nature 2011, 477:229-233.
6. Lee C.H., Hong C.H., Yu W.T., Chuang H.Y., Huang S.K., Chen G.S., et al. Mechanistic correlations between two itch biomarkers, cytokine interleukin-31 and neuropeptide beta-endorphin, via STAT3/calcium axis in atopic dermatitis. Br J Dermatol 2012, 167:794-803.
7. Veldhoen M., Uyttenhove C., van Snick J., Helmby H., Westendorf A., Buer J., et al. Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat Immunol 2008, 9:1341-1346.
8. Soroosh P., Doherty T.A. Th9 and allergic disease. Immunology 2009, 127:450-458.
9. Chang H.C., Sehra S., Goswami R., Yao W., Yu Q., Stritesky G.L., et al. The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation. Nat Immunol 2010, 11:527-534.
10. Staudt V., Bothur E., Klein M., Lingnau K., Reuter S., Grebe N., et al. Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells. Immunity 2010, 33:192-202.
11. Little F.F., Cruikshank W.W., Center D.M. Il-9 stimulates release of chemotactic factors from human bronchial epithelial cells. Am J Respir Cell Mol Biol 2001, 25:347-352.
12. Dragon S., Takhar M.K., Shan L., Hayglass K.T., Simons F.E., Gounni A.S. T(H)2 cytokines modulate the IL-9R expression on human neutrophils. Biochem Biophys Res Commun 2009, 384:167-172.
13. Sismanopoulos N., Delivanis D.A., Alysandratos K.D., Angelidou A., Vasiadi M., Therianou A., et al. IL-9 induces VEGF secretion from human mast cells and IL-9/IL-9 receptor genes are overexpressed in atopic dermatitis. PLoS ONE 2012, 7:e33271.
14. Fawaz L.M., Sharif-Askari E., Hajoui O., Soussi-Gounni A., Hamid Q., Mazer B.D. Expression of IL-9 receptor alpha chain on human germinal center B cells modulates IgE secretion. J Allergy Clin Immunol 2007, 120:1208-1215.
15. Gounni A.S., Hamid Q., Rahman S.M., Hoeck J., Yang J., Shan L. IL-9-mediated induction of eotaxin1/CCL11 in human airway smooth muscle cells. J Immunol 2004, 173:2771-2779.
16. Purwar R., Schlapbach C., Xiao S., Kang H.S., Elyaman W., Jiang X., et al. Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells. Nat Med 2012.
17. Singh T.P., Schon M.P., Wallbrecht K., Gruber-Wackernagel A., Wang X.J., Wolf P. Involvement of IL-9 in Th17-associated inflammation and angiogenesis of psoriasis. PLoS ONE 2013, 8:e51752.
18. Temann U.A., Geba G.P., Rankin J.A., Flavell R.A. Expression of interleukin 9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness. J Exp Med 1998, 188:1307-1320.
19. Temann U.A., Ray P., Flavell R.A. Pulmonary overexpression of IL-9 induces Th2 cytokine expression, leading to immune pathology. J Clin Invest 2002, 109:29-39.
20. Cheng G., Arima M., Honda K., Hirata H., Eda F., Yoshida N., et al. Anti-interleukin-9 antibody treatment inhibits airway inflammation and hyperreactivity in mouse asthma model. Am J Respir Crit Care Med 2002, 166:409-416.
21. Vermeer P.D., Harson R., Einwalter L.A., Moninger T., Zabner J. Interleukin-9 induces goblet cell hyperplasia during repair of human airway epithelia. Am J Respir Cell Mol Biol 2003, 28:286-295.
22. Toda M., Tulic M.K., Levitt R.C., Hamid Q. A calcium-activated chloride channel (HCLCA1) is strongly related to IL-9 expression and mucus production in bronchial epithelium of patients with asthma. J Allergy Clin Immunol 2002, 109:246-250.
23. Tsicopoulos A., Shimbara A., de Nadai P., Aldewachi O., Lamblin C., Lassalle P., et al. Involvement of IL-9 in the bronchial phenotype of patients with nasal polyposis. J Allergy Clin Immunol 2004, 113:462-469.
24. Wang T.N., Chen W.Y., Huang Y.F., Shih N.H., Feng W.W., Tseng H.I., et al. The synergistic effects of the IL-9 gene and environmental exposures on asthmatic Taiwanese families as determined by the transmission/disequilibrium test. Int J Immunogenet 2006, 33:105-110.
25. Ciprandi G., De Amici M., Giunta V., Marseglia A., Marseglia G. Serum interleukin-9 levels are associated with clinical severity in children with atopic dermatitis. Pediatr Dermatol 2012.
26. Namkung J.H., Lee J.E., Kim E., Park G.T., Yang H.S., Jang H.Y., et al. An association between IL-9 and IL-9 receptor gene polymorphisms and atopic dermatitis in a Korean population. J Dermatol Sci 2011, 62:16-21.
27. Lee C.H., Wu S.B., Hong C.H., Chen G.S., Wei Y.H., Yu H.S. Involvement of mtDNA damage elicited by oxidative stress in the arsenical skin cancers. J Invest Dermatol 2013.
28. Lee C.H., Hong C.H., Chen Y.T., Chen Y.C., Shen M.R. TGF-beta1 increases cell rigidity by enhancing expression of smooth muscle actin: keloid-derived fibroblasts as a model for cellular mechanics. J Dermatol Sci 2012, 67:173-180.
29. Lee C.H., Wu S.B., Hong C.H., Liao W.T., Wei Y.H., Yu H.S. Aberrant cell proliferation by mitochondrial biogenesis and mtTFA in arsenical cancers. Am J Pathol 2013, 133:1890-1900.
30. Yamasaki A., Saleh A., Koussih L., Muro S., Halayko A.J., Gounni A.S. IL-9 induces CCL11 expression via STAT3 signalling in human airway smooth muscle cells. PLoS ONE 2010, 5:e9178.
31. Kimata H., Lindley I. Detection of plasma interleukin-8 in atopic dermatitis. Arch Dis Child 1994, 70:119-122.
32. Amarbayasgalan T., Takahashi H., Dekio I., Morita E. Interleukin-8 content in the stratum corneum as an indicator of the severity of inflammation in the lesions of atopic dermatitis. Int Arch Allergy Immunol 2013, 160:63-74.
33. Casas C., Ribet V., Alvarez-Georges S., Sibaud V., Guerrero D., Schmitt A.M., et al. Modulation of Interleukin-8 and staphylococcal flora by Avene hydrotherapy in patients suffering from chronic inflammatory dermatoses. J Eur Acad Dermatol Venereol 2011, 25(Suppl. 1):19-23.
34. Kuchler S., Henkes D., Eckl K.M., Ackermann K., Plendl J., Korting H.C., et al. Hallmarks of atopic skin mimicked in vitro by means of a skin disease model based on FLG knock-down. Altern Lab Anim 2011, 39:471-480.
35. Kezic S., O'Regan G.M., Lutter R., Jakasa I., Koster E.S., Saunders S., et al. Filaggrin loss-of-function mutations are associated with enhanced expression of IL-1 cytokines in the stratum corneum of patients with atopic dermatitis and in a murine model of filaggrin deficiency. J Allergy Clin Immunol 2012, 129. 1031-9.e1.
36. Neuber K., Hilger R.A., Konig W. Interleukin-3, interleukin-8, FMLP and C5a enhance the release of leukotrienes from neutrophils of patients with atopic dermatitis. Immunology 1991, 73:83-87.
37. Ohnishi H., Miyahara N., Gelfand E.W. The role of leukotriene B(4) in allergic diseases. Allergol Int 2008, 57:291-298.
38. Bonecchi R., Facchetti F., Dusi S., Luini W., Lissandrini D., Simmelink M., et al. Induction of functional IL-8 receptors by IL-4 and IL-13 in human monocytes. J Immunol 2000, 164:3862-3869.
39. McGirt L.Y., Beck L.A. Innate immune defects in atopic dermatitis. J Allergy Clin Immunol 2006, 118:202-208.
40. Fontaine R.H., Cases O., Lelievre V., Mesples B., Renauld J.C., Loron G., et al. IL-9/IL-9 receptor signaling selectively protects cortical neurons against developmental apoptosis. Cell Death Differ 2008, 15:1542-1552.
41. Dejean E., Foisseau M., Lagarrigue F., Lamant L., Prade N., Marfak A., et al. ALK+ALCLs induce cutaneous, HMGB-1-dependent IL-8/CXCL8 production by keratinocytes through NF-kappaB activation. Blood 2012, 119:4698-4707.
42. Wu S., Gao J., Dinh Q.T., Chen C., Fimmel S. IL-8 production and AP-1 transactivation induced by UVA in human keratinocytes: roles of D-alpha-tocopherol. Mol Immunol 2008, 45:2288-2296.
43. Tsuji G., Takahara M., Uchi H., Takeuchi S., Mitoma C., Moroi Y., et al. An environmental contaminant, benzo(a)pyrene, induces oxidative stress-mediated interleukin-8 production in human keratinocytes via the aryl hydrocarbon receptor signaling pathway. J Dermatol Sci 2011, 62:42-49.
44. Balghi H., Robert R., Rappaz B., Zhang X., Wohlhuter-Haddad A., Evagelidis A., et al. Enhanced Ca2+ entry due to Orai1 plasma membrane insertion increases IL-8 secretion by cystic fibrosis airways. FASEB J 2011, 25:4274-4291.
45. Baraldo S., Faffe D.S., Moore P.E., Whitehead T., McKenna M., Silverman E.S., et al. Interleukin-9 influences chemokine release in airway smooth muscle: role of ERK. Am J Physiol Lung Cell Mol Physiol 2003, 284:L1093-L1102.
46. Liu J., Harberts E., Tammaro A., Girardi N., Filler R.B., Fishelevich R., et al. IL-9 regulates allergen-specific Th1 responses in allergic contact dermatitis. J Invest Dermatol 2014.
47. Yao W., Zhang Y., Jabeen R., Nguyen E.T., Wilkes D.S., Tepper R.S., et al. Interleukin-9 is required for allergic airway inflammation mediated by the cytokine TSLP. Immunity 2013, 38:360-372.
48. Liu J., Harberts E., Tammaro A., Girardi N., Filler R.B., Fishelevich R., et al. IL-9 regulates allergen-specific Th1 responses in allergic contact dermatitis. J Invest Dermatol 2014, 134:1903-1911.